Tuberculous optochiasmatic arachnoiditis: A devastating form of tuberculous meningitis

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 9, 2011, Pages 719-729

  Garg, Ravindra Kumar ^a   Paliwal, Vimal ^b   Malhotra, Hardeep Singh ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

arachnoiditis; meningitis; Mycobacterium tuberculosis; optic nerve; suprasellar cistern; tuberculoma; tuberculosis; vision loss

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETHIONAMIDE; HYALURONIDASE; INFLIXIMAB; LEVOFLOXACIN; METHYLPREDNISOLONE; PROTEIN; THALIDOMIDE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASAL EXUDATE; BRAIN DECOMPRESSION; BRAIN VASCULITIS; BRAIN VENTRICLE PERITONEUM SHUNT; CYTOKINE RELEASE; DISEASE ASSOCIATION; EXUDATE; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; MEDICAL DECISION MAKING; MENINGITIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; TERATOGENICITY; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS; TUBERCULOUS OPTOCHIASMATIC ARACHNOIDITIS; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; ARACHNOID; ARACHNOIDITIS; BLINDNESS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROCEPHALUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OPTIC CHIASM; SPINAL CORD; TUBERCULOMA; TUBERCULOSIS, MENINGEAL;

EID: 80052705940     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.93     Document Type: Article

References (53)

1. Sinha MK, Garg RK, Anuradha HK, Agarwal A, Parihar A, Mandhani PA. Paradoxical vision loss associated with optochiasmatic tuberculoma in tuberculous meningitis: a report of 8 patients. J. Infect. 60, 458-466 (2010).
2. Sinha MK, Garg RK, Anuradha HK et al. Vision impairment in tuberculous meningitis: predictors and prognosis. J. Neurol. Sci. 290, 27-32 (2010).
3. Anupriya A, Sunithi M, Maya T et al. Tuberculous optochiasmatic arachnoiditis. Neurol. India 58, 732-735 (2010).
4. Gourie-Devi M. Optochiasmatic arachnoiditis and neurotuberculosis: prognostic indicators and therapeutic strategies. Neurol. India 58, 714-715 (2010).
5. Balado M, Satanowsky P. Tratamiento quirurgico de la atrofia de la papila. Arch. Argent. Neurol. 4, 71-75 (1929).
6. Yuhl ET, Rand CW. Tuberculous optochiasmatic arachnoiditis. Report of a case. J. Neurosurg. 8, 441-443 (1951).
7. De Lavergne V, Pierquin, Helluy, Martin JY. Complication of meningeal tuberculosis, optochiasmatic arachnoiditis; arrest of its development by cortisone used early. Rev. Med. Nancy 79, 134-140 (1954).
8. Rougier J, Lapras C, Fischer G, Hullo A. Two new cases of optochiasmatic arachnoiditis in the infant and child. Bull. Soe. Ophtalmol. Fr. 80, 179-183 (1980).
9. Scott RM, Sonntag VK, Wilcox LM, Adelman LS, Rockel TH. Visual loss from optochiasmatic arachnoiditis after tuberculous meningitis. Case report. J. Neurosurg. 46, 524-526 (1977). (Pubitemid 8067480)
10. Ib-Zizen MT, Cabanis EA, Tamraz JC, Braun M, Lopez A, Godde-Jolly D. Magnetic resonance imaging of the opto-chiasmatic region. Report on 276 cases. Acta. Radiol. Suppl. 369, 318-319 (1986).
11. Aylward EH, Karagiozis H, Pearlson G, Folstein MF. Suprasellar cistern measures as a reflection of dementia in Alzheimer's disease but not Huntington's disease. J. Psychiatr. Res. 25, 31-47 (1991).
12. Garg RK. Tuberculous meningitis. Acta. Neurol. Scand. 122, 75-90 (2010).
13. Subramanian PC. Bacteria and bacterial diseases. In: Walsh and Hoyt's Clinical Neuro-ophthalmology. Volume 3 (6th Edition).Miller NR, Fletcher W (Eds).Lippincott Williams and Wilkins, Baltimore, MD, USA, 2647-2774 (2005).
14. Teoh R, Poon W, Humphries MJ, O'Mahony G. Suprasellar tuberculoma developing during treatment of tuberculous meningitis requiring urgent surgical decompression. J. Neurol. 235, 321-322 (1988).
15. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin. Infect. Dis. 19, 1092-1099 (1994). (Pubitemid 24380024)
16. Nicolls DJ, King M, Holland D, Bala J, del Rio C. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect. Dis. 5, 795-801 (2005). (Pubitemid 41688984)
17. Marais S, Scholtz P, Pepper DJ, Meintjes G, Wilkinson RJ, Candy S. Neuroradiological features of the tuberculosis-αssociated immune reconstitution inflammatory syndrome. Int. J. Tuberc. Lung Dis. 14, 188-196 (2010).
18. Ray JC, Flynn JL, Kirschner DE. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 182, 3706-3717 (2009).
19. Paige C, Bishai WR. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view. Cell. Microbiol. 12, 301-309 (2010).
20. Green JA, Thi Hong Chau T, Farrar JJ, Friedland JS, Thwaites GE. CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features. Neurology 76, 577-579 (2011).
21. Tsai MH, Huang YC, Lin TY. Development of tuberculoma during therapy presenting as hemianopsia. Pediatr. Neurol. 31, 360-363 (2004).
22. Akhaddar A, El Hassani MY, Chakir N, Jiddane M. Optochiasmatic tuberculoma: complication of tuberculous meningitis: report of a case and review of the literature. J. Neuroradiol. 28, 137-142 (2001). (Pubitemid 32701471)
23. Sharma K, Pradhan S, Varma A, Rathi B. Irreversible blindness due to multiple tuberculomas in the suprasellar cistern. J. Neuro-Ophthalmol. 23, 211-212 (2003). (Pubitemid 37158736)
24. Beneggi A, Adamoli P, Bernardini E et al. Tuberculous meningitis: a case with severe ocular complications. Pediatr. Med. Chir. 17, 465-469 (1995).
25. Dautremer J, Pacanowski J, Girard PM, Lalande V, Sivignon F, Meynard JL. A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1- infected patient with tuberculous meningitis. AIDS 21, 381-382 (2007). (Pubitemid 46175055)
26. Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J. Neurol. Sci. 303, 22-30 (2011).
27. Bernaerts A, Vanhoenacker FM, Parizel PM et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur. Radiol. 13, 1876-1890 (2003). (Pubitemid 36949714)
28. Clavier E, Thiebot J, Freger P, Mihout B, Bernet J, Benozio M. Optochiasmatic tuberculoma and MRI: 2 cases. J. Radiol. 69, 333-337 (1988).
29. Aversa do Souto A, Fonseca AL, Gadelha M, Donangelo I, Chimelli L, Domingues FS. Optic pathways tuberculoma mimicking glioma: case report. Surg. Neurol. 60, 349-353 (2003). (Pubitemid 37162642)
30. Marcus AO, Demakas JJ, Ross HA, Duick DS, Crowell RM. Optochiasmatic arachnoiditis with treatment by surgical lysis of adhesions, corticosteroids, and cyclophosphamide: report of a case. Neurosurgery 19, 101-103 (1986). (Pubitemid 16076088)
31. Navarro IM, Peralta VH, Leon JA, Varela EA, Cabrera JM. Tuberculous optochiasmatic arachnoiditis. Neurosurgery 9, 654-660 (1981). (Pubitemid 12196165)
32. Thwaites GE, Nguyen DB, Nguyen HD et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N. Engl. J. Med. 351, 1741-1751 (2004).
33. Green JA, Elkington PT, Pennington CJ et al. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kB- and activator protein-1-dependent monocyte networks. J. Immunol. 184, 6492-6503 (2010).
34. Green JA, Tran CT, Farrar JJ et al. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS ONE 4, e7277 (2009).
35. Roberts MT, Mendelson M, Meyer P, Carmichael A, Lever AM. The use of thalidomide in the treatment of intracranial tuberculomas in adults: two case reports. J. Infect. 47, 251-255 (2003). (Pubitemid 37168626)
36. Schoeman JF, Andronikou S, Stefan DC, Freeman N, van Toorn R. Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases. J. Child. Neurol. 25, 822-828 (2010).
37. Buonsenso D, Serranti D, Valentini P. Management of central nervous system tuberculosis in children: light and shade. Eur. Rev. Med. Pharmacol. Sci. 14, 845-853 (2010).
38. Schoeman JF, Springer P, van Rensburg AJ et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. J. Child. Neurol. 19, 250-257 (2004). (Pubitemid 38660206)
39. Gourie-Devi M, Satish Chandra P. Hyaluronidase as an adjuvant in the treatment of cranial arachnoiditis (Hydrocephalus and optochiasmatic arachnoiditis) complicating tuberculous meningitis. Acta. Neurol. Scand. 62, 368-381 (1980). (Pubitemid 11200542)
40. Hejazi N, Hassler W. Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Infection 25, 233-239 (1997). (Pubitemid 27348158)
41. Kalkan A, Serhatlioglu S, Ozden M et al. Paradoxically developed optochiasmatic tuberculoma and tuberculous lymphadenitis: a case report with 18-month follow-up by MRI. South Med. J. 99, 388-392 (2006).
42. Poon WS, Ahuja A, Li AK. Optochiasmatic tuberculoma causing progressive visual failure: when has medical treatment failed? Postgrad. Med. J. 69, 147-149 (1993). (Pubitemid 23120773)
43. Blackmore TK, Manning L, Taylor WJ, Wallis RS. Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin. Infect. Dis. 47, e83-e85 (2008).
44. Stefan DC, Andronikou S, Freeman N, Schoeman J. Recovery of vision after adjuvant thalidomide in a child with tuberculous meningitis and acute lymphoblastic leukemia. J. Child. Neurol. 24, 166-169 (2009).
45. Yeh S, Cunningham MA, Patronas N, Foroozan R. Optic neuropathy and perichiasmal tuberculomas associated with Mycobacterium tuberculosis meningitis in pregnancy. Can. J. Ophthalmol. 44, 713-715 (2009).
46. Sunbul M, Leblebicioglu H, Turan D et al. Permanent visual loss despite appropriate therapy in tuberculous meningitis. South Med. J. 100, 228-229 (2007). (Pubitemid 46213780)
47. Meyer S, Struffert T, Gottschling S. Tuberculous meningitis. Lancet 367, 1682 (2006). (Pubitemid 43728232)
48. Sodhi PK, Grover SB, D Singh, Gulati P. Diagnosis of optochiasmatic tuberculosis revealed by computed tomography and magnetic resonance imaging. Ann. Ophthalmol. 33, 252-256 (2001).
49. Silverman IE, Liu GT, Bilaniuk LT, Volpe NJ, Galetta SL. Tuberculous meningitis with blindness and perichiasmal involvement on MRI. Pediatr. Neurol. 12, 65-67 (1995).
50. Kingsley DP, Hendrickse WA, Kendall BE, Swash M, Singh V. Tuberculous meningitis: role of CT in management and prognosis. J. Neurol. Neurosurg. Psychiatry 50, 30-36 (1987). (Pubitemid 17218353)
51. Ghosh AK, Agrawal A, Singhal S. Tubercular optochiasmatic arachnoiditis. Iranian J. Radiol. 6, 101-102 (2009).
52. Schoeman JF, Fieggen G, Seller N, Mendelson M, Hartzenberg B. Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases. J. Child. Neurol. 21, 301-308 (2006). (Pubitemid 43891127)
53. Aliyu SH, Ganesan D, Enoch DA, Watts C, Lever AML. Tuberculous meningitis and hydrocephalus treated successfully with a combination of immunomodulation and cerebrospinal fluid diversion. Infect. Dis. J. Pak. 16, 22-24 (2007).